Dyne Therapeutics Announces Proposed Public Offering of Common Stock
Dyne Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire December 08, 2025 WALTHAM, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has commenced an underwritten public offering of $300,000,000 of […]